nvestor presentation First six months of 2019 Slide 25 itions in diabetes, obesity and esity value ordisk value market share market position #1 90% 80% 70% 60% 50% ue: 11.7% 40% 30% 20% 10% 0% May 2019 alue figures DKK billion 80 Haemophilia Market value Novo Nordisk value market share Global market position #2 50% 60 40% 30% 40 CAGR1 value: 1.1% 20% 20 10% 0 FY 2014 0% FY 2018 3 CAGR for 5-year period Note: Annual sales figures for haemophilia A, B and bypassing agents segment. Recombinant and plasma derived products Source: Company reports
Download PDF file